SciQuest Announces First Quarter Results

Published 4:07 PM ET Thu, 30 April 2015
Globe Newswire

MORRISVILLE, N.C., April 30, 2015 (GLOBE NEWSWIRE) -- SciQuest, Inc. (Nasdaq:SQI), a leading provider of cloud-based business automation solutions for spend management, today announced its financial results for the first quarter ended March 31, 2015.

"We delivered solid financial results in the first quarter as we generated revenue and profitability that were at the top of their respective guidance ranges. During the quarter, we continued to execute against our long-term priorities, selling solutions to both new and existing customers while we advanced operational efficiency," said Stephen Wiehe, President and Chief Executive Officer of SciQuest. "We augmented the depth of our broad platform by delivering our latest release and introducing two new features enabled by new partners. During the quarter, Gartner, Inc. recognized us as a 'Leader' in its 2015 Magic Quadrant for Procure-to-Pay Suites for Indirect Procurement report, reinforcing the strength of our technology and high customer satisfaction levels. As a result of our first quarter performance and accomplishments, we are on track to achieve our growth and profitability goals for the year."

First Quarter 2015 Results

SciQuest reported GAAP revenues of $25.9 million for the quarter ended March 31, 2015 compared to $25.4 million in the first quarter of 2014.

GAAP loss from operations in the first quarter of 2015 was $0.5 million compared to GAAP loss from operations of $0.1 million in the first quarter of 2014. GAAP net loss was $0.3 million in the first quarter of 2015 compared to GAAP net income of $0.1 million in the same quarter in the prior year.

GAAP basic net loss per share was $0.01 in the first quarter of 2015 based on 27.6 million weighted average basic shares outstanding. GAAP diluted net income per share in the first quarter of 2014 was breakeven based on 24.5 million weighted average diluted shares outstanding.

Non-GAAP revenues(1) in the first quarter was $26.0 million, roughly in-line with non-GAAP revenues in the prior year. Non-GAAP income from operations(2) in the first quarter of 2015 was $2.2 million compared to non-GAAP income from operations(2) of $3.5 million in the first quarter of 2014. Non-GAAP net income(3) in the first quarter of 2015 was $1.3 million compared to non-GAAP net income(3) in the first quarter of 2014 of $2.1 million.

Non-GAAP diluted net income per share(3) was $0.05 in the first quarter of 2015 based on 27.9 million weighted average diluted shares outstanding. Non-GAAP diluted net income per share(3) in the first quarter of 2014 was $0.09 based on 24.5 million weighted average diluted shares outstanding.

Business Outlook

SciQuest is issuing the following guidance for the second quarter and affirming its full year guidance initially provided on February 5, 2015:

Second Quarter 2015

GAAP revenues between $26.3 million and $26.6 million.

GAAP basic net loss per share between ($0.01) and ($0.00).

Weighted average basic shares outstanding of approximately 27.7 million.

Non-GAAP revenues(1) between $26.3 million and $26.6 million.

Non-GAAP diluted net income per share(3) between $0.06 and $0.07.

Weighted average diluted shares outstanding of approximately 28.0 million.

Full Year 2015

GAAP revenues between $105.9 million and $109.9 million.

GAAP diluted net income per share between $0.02 and $0.06.

Weighted average diluted shares outstanding of approximately 28.0 million.

Net cash provided by operating activities between $21.5 million and $23.5 million.

Capitalization of software development costs of approximately $6.0 million, purchase of property and equipment of approximately $2.5 million.

Non-GAAP revenues(1) between $106.0 million and $110.0 million.

Non-GAAP diluted net income per share(3) between $0.29 and $0.33.

Adjusted free cash flow(4) between $13.0 million and $15.0 million.

A reconciliation of the most comparable GAAP financial measure to the non-GAAP measures used above is included with the financial tables at the end of this release.

SciQuest provides all information required in accordance with GAAP, but believes evaluating its ongoing operating results may not be as useful if an investor is limited to reviewing only GAAP financial measures. Accordingly, SciQuest presents non-GAAP financial measures in reporting its financial results to provide investors with additional tools to evaluate SciQuest's operating results in a manner that focuses on what SciQuest believes to be its ongoing business operations and what SciQuest uses to evaluate its ongoing operations and for internal planning and forecasting purposes. SciQuest's management does not itself, nor does it suggest that investors should, consider such non-GAAP financial measures in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. SciQuest's management believes it is useful for itself and investors to review, as applicable, both GAAP information that includes: (i) amortization of intangible assets and acquired software; (ii) stock-based compensation; (iii) purchase accounting deferred revenue adjustment; (iv) other significant items, when applicable; and (v) the beneficial income tax effect related to these included items; and the non-GAAP measures that exclude such information in order to assess the performance of SciQuest's business and for planning and forecasting in subsequent periods. Whenever SciQuest uses such a non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most closely applicable GAAP financial measure to the extent possible. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed herein.

About SciQuest

SciQuest (Nasdaq:SQI) spend management solutions enable procurement, sourcing and financial professionals to focus on strategic decisions that transform business processes. Our feature-rich products and expert services help hundreds of organizations, including leading global companies, drive bottom line results by improving, automating and optimizing their source-to-settle processes.

Learn more about our solutions and how we can help your organization turn spending into savings at www.sciquest.com.

Forward-looking statements include information concerning SciQuest's possible or assumed future results of operations, business strategies, financing plans, competitive position, industry environment, potential growth opportunities, potential market opportunities, the effects of competition and other factors that could impact future performance. In particular, forward-looking statements include references to achieving growth and profitability goals for the year and all statements in the "Business Outlook" section. Forward-looking statements consist of statements that are not historical facts and can be identified by terms such as, but not limited to, "accelerates", "anticipates," "believes," "could," "seeks," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "will," "would" or similar expressions and the negatives of those terms. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Certain of these risks are discussed in "Part I, Item 1A, Risk Factors" and elsewhere in SciQuest's most recent Annual Report on Form 10-K and other reports, as filed with the United States Securities and Exchange Commission ("SEC"). In particular, we call your attention to the risk factors in our Annual Report on Form 10-K entitled "Our actual operating results may differ significantly from our guidance", "If we are unable to attract new customers, or if our existing customers do not purchase additional products or services, the growth of our business and cash flows will be adversely affected", "Our failure to sustain our historical renewal rates, pricing and terms of our customer contracts would adversely affect our operating results" and "We are subject to a lengthy sales cycle and delays or failures to complete sales may harm our business and result in slower growth." The company's SEC reports are available free of charge on the SEC's website at http://www.sec.gov or on the company's website at www.sciquest.com. All forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Also, forward-looking statements represent management's beliefs and assumptions only as of the date of this release. Except as required by law, SciQuest assumes no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results.

SQI-F

SCIQUEST, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands except per share amounts)

As of March 31,

As of December 31,

2015

2014

(unaudited)

Assets

Current assets:

Cash and cash equivalents

$ 55,856

$ 59,419

Short-term investments

71,470

71,493

Accounts receivable, net

8,710

12,032

Prepaid expenses and other current assets

2,832

2,666

Deferred tax asset

410

400

Total current assets

139,278

146,010

Property and equipment, net

13,988

13,595

Goodwill

62,532

63,779

Intangible assets, net

22,245

23,846

Deferred commissions

5,771

6,094

Deferred tax asset, less current portion

11,945

11,657

Other

331

234

Total assets

$ 256,090

$ 265,215

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable

$ 232

$ 375

Accrued liabilities

7,198

10,051

Deferred revenues

55,356

59,751

Total current liabilities

62,786

70,177

Deferred revenues, less current portion

10,040

11,350

Deferred rent, less current portion

1,995

2,027

Stockholders' equity:

Common stock, $0.001 par value; 50,000 shares authorized; 27,584 and 27,574 shares issued and outstanding as of March 31, 2015 and December 31, 2014, respectively

28

28

Additional paid-in capital

205,605

204,065

Accumulated other comprehensive loss

(4,698)

(3,055)

Accumulated deficit

(19,666)

(19,377)

Total stockholders' equity

181,269

181,661

Total liabilities and stockholders' equity

$ 256,090

$ 265,215

SCIQUEST, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(in thousands except per share amounts)

Three Months Ended March 31,

2015

2014

(unaudited)

Revenues

$ 25,941

$ 25,407

Cost of revenues (1)(2)

8,328

7,670

Gross profit

17,613

17,737

Operating expenses: (1)

Research and development

7,072

6,927

Sales and marketing

7,006

6,960

General and administrative

3,349

3,110

Amortization of intangible assets

735

797

Total operating expenses

18,162

17,794

Loss from operations

(549)

(57)

Other (expense) income, net:

Interest income

150

6

Other (expense) income, net

(188)

(9)

Total other (expense) income, net

(38)

(3)

Loss before income taxes

(587)

(60)

Income tax benefit

298

126

Net (loss) income

$ (289)

$ 66

Other comprehensive loss:

Foreign currency translation adjustments

(1,643)

(757)

Comprehensive loss

$ (1,932)

$ (691)

Net (loss) income per share

Basic

$ (0.01)

$ 0.00

Diluted

$ (0.01)

$ 0.00

Weighted average shares outstanding used in computing per share amounts

Basic

27,584

23,908

Diluted

27,584

24,499

(1) Amounts include stock-based compensation expense, as follows:

Three Months Ended March 31,

2015

2014

(unaudited)

Cost of revenues

$ 185

$ 163

Research and development

128

180

Sales and marketing

370

362

General and administrative

786

758

$ 1,469

$ 1,463

(2) Cost of revenues includes amortization of capitalized software development costs of:

Amortization of capitalized software development costs:

$ 917

$ 558

Amortization of acquired software:

497

520

$ 1,414

$ 1,078

SCIQUEST, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Three Months Ended March 31,

2015

2014

(unaudited)

Cash flows from operating activities

Net (loss) income

$ (289)

$ 66

Adjustments to reconcile net (loss) income to net cash used in operating activities:

Depreciation and amortization

2,889

2,485

Stock-based compensation expense

1,469

1,463

Deferred taxes

(298)

(86)

Changes in operating assets and liabilities:

Accounts receivable

3,274

3,017

Prepaid expense and other current assets

(181)

805

Deferred commissions and other assets

216

418

Accounts payable

(143)

(392)

Accrued liabilities

(3,076)

(6,521)

Deferred revenues

(5,561)

(3,101)

Deferred rent

(32)

--

Net cash used in operating activities

(1,732)

(1,846)

Cash flows from investing activities

Addition of capitalized software development costs

(1,483)

(1,308)

Purchase of property and equipment

(736)

(174)

Purchase of short-term investments

(32,478)

--

Maturities of short-term investments

32,500

--

Net cash used in investing activities

(2,197)

(1,482)

Cash flows from financing activities

Proceeds from exercise of common stock options

71

292

Proceeds from employee stock purchase plan activity

272

--

Net cash provided by financing activities

343

292

Effect of exchange rate change on cash and cash equivalents

23

(14)

Net decrease in cash and cash equivalents

(3,563)

(3,050)

Cash and cash equivalents at beginning of the period

59,419

19,117

Cash and cash equivalents at end of the period

$ 55,856

$ 16,067

RECONCILIATION DATA

(UNAUDITED)

(in thousands except per share amounts)

Reconciliation of Net (Loss) Income to Non-GAAP Net Income:

Three Months Ended March 31,

2015

2014

Net (loss) income

$ (289)

$ 66

Purchase accounting deferred revenue adjustment

28

747

Amortization of intangible assets

735

797

Amortization of acquired software

497

520

Stock-based compensation

1,469

1,463

Tax effect of adjustments

(1,132)

(1,476)

Non-GAAP net income

$ 1,308

$ 2,117

Non-GAAP net income per share:

Basic

$ 0.05

$ 0.09

Diluted

$ 0.05

$ 0.09

Weighted average shares outstanding used in computing per share amounts:

Basic

27,584

23,908

Diluted

27,889

24,499

Reconciliation of Loss from Operations to Non-GAAP Income from Operations:

Three Months Ended March 31,

2015

2014

Loss from operations

$ (549)

$ (57)

Purchase accounting deferred revenue adjustment

28

747

Amortization of intangible assets

735

797

Amortization of acquired software

497

520

Stock-based compensation

1,469

1,463

Non-GAAP income from operations

$ 2,180

$ 3,470

Reconciliation of Operating Expenses to Non-GAAP Operating Expenses:

Three Months Ended March 31,

2015

2014

Operating expenses

$ 18,162

$ 17,794

Amortization of intangible assets

(735)

(797)

Stock-based compensation

(1,284)

(1,300)

Non-GAAP operating expenses

$ 16,143

$ 15,697

Reconciliation of Net Cash Used in Operating Activities to Adjusted Free Cash Flow:

Three Months Ended March 31,

2015

2014

Net cash used in operating activities

$ (1,732)

$ (1,846)

Purchase of property and equipment

(736)

(174)

Capitalization of software development costs

(1,483)

(1,308)

Free cash flow

(3,951)

(3,328)

Acquisition related costs

--

3,600

Adjusted free cash flow

$ (3,951)

$ 272

RECONCILIATION DATA

(UNAUDITED)

(in thousands)

Reconciliation of Revenues to Non-GAAP Revenues:

Three Months Ended March 31,

2015

2014

Revenues

$ 25,941

$ 25,407

Purchase accounting deferred revenue adjustment

28

747

Non-GAAP Revenues

$ 25,969

$ 26,154

Reconciliation of Cost of Revenues to Non-GAAP Cost of Revenues:

Three Months Ended March 31,

2015

2014

Cost of revenues

$ 8,328

$ 7,670

Amortization of acquired software

(497)

(520)

Stock-based compensation

(185)

(163)

Non-GAAP Cost of revenues

$ 7,646

$ 6,987

Reconciliation of Research and Development to Non-GAAP Research and Development:

Three Months Ended March 31,

2015

2014

Research and development

$ 7,072

$ 6,927

Stock-based compensation

(128)

(180)

Non-GAAP Research and development

$ 6,944

$ 6,747

Reconciliation of Sales and Marketing to Non-GAAP Sales and Marketing:

Three Months Ended March 31,

2015

2014

Sales and marketing

$ 7,006

$ 6,960

Stock-based compensation

(370)

(362)

Non-GAAP Sales and marketing

$ 6,636

$ 6,598

Reconciliation of General and Administrative to Non-GAAP General and Administrative:

Three Months Ended March 31,

2015

2014

General and administrative

$ 3,349

$ 3,110

Stock-based compensation

(786)

(758)

Non-GAAP General and administrative

$ 2,563

$ 2,352

Reconciliation of Amortization of Intangible Assets to Non-GAAP Amortization of Intangible Assets:

Three Months Ended March 31,

2015

2014

Amortization of intangible assets

$ 735

$ 797

Amortization of intangible assets

(735)

(797)

Non-GAAP Amortization of intangible assets

$ --

$ --

RECONCILIATION DATA

(UNAUDITED)

(in thousands except per share amounts)

Reconciliation of Revenue Outlook to Non-GAAP Revenue Outlook:

Three Months Ended June 30, 2015

Twelve Months Ended December 31, 2015

Low end of Range

High end of Range

Low end of Range

High end of Range

Revenues

$ 26,300

$ 26,600

$ 105,900

$ 109,900

Purchase accounting deferred revenue adjustment

--

--

100

100

Non-GAAP revenues

$ 26,300

$ 26,600

$ 106,000

$ 110,000

Reconciliation of (Loss) Earnings per Share Outlook to Non-GAAP Earnings per Share Outlook:

Three Months Ended June 30, 2015

Twelve Months Ended December 31, 2015

Low end of Range

High end of Range

Low end of Range

High end of Range

(Loss) Earnings per Share

$ (0.01)

$ --

$ 0.02

$ 0.06

Purchase accounting deferred revenue adjustment per share

--

--

--

--

Amortization of intangible assets per share and acquired software per share